NKTR
Nektar Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NKTR fundamentals
Nektar Therapeutics (NKTR) released its earnings on Nov 6, 2025: revenue was 11.79M (YoY -51.13%), beat estimates; EPS was -1.87 (YoY -938.89%), beat estimates.
Revenue / YoY
11.79M
-51.13%
EPS / YoY
-1.87
-938.89%
Report date
Nov 6, 2025
NKTR Earnings Call Summary for Q3,2025
- REZPEG Clinical Momentum: Phase IIb data in atopic dermatitis and alopecia areata set for December 2025 readouts, with potential Phase III starts in 2026.
- Treg Innovation: Unique IL-2 signaling mechanism addresses unmet needs in autoimmune diseases, highlighted by Nobel Prize recognition.
- Financial Strength: $240 million cash balance extends runway to Q2 2027, supporting dual-track development of REZPEG and pipeline assets.
- Strategic Differentiation: REZPEG's safety profile and remittive potential position it as a first-in-class biologic in multiple indications.
EPS
Revenue
Revenue & Expenses
NKTR has released its 2025 Q3 earnings report, with revenue of 11.79M, reflecting a YoY change of -51.13%, and net profit of -35.52M, showing a YoY change of 4.14%. The Sankey diagram below clearly presents NKTR's revenue sources and cost distribution.
Key Indicators
Nektar Therapeutics (NKTR) key financial stats and ratios, covering profitability, financial health, and leverage.
Nektar Therapeutics (NKTR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Nektar Therapeutics (NKTR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Nektar Therapeutics (NKTR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Nektar Therapeutics (NKTR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Nektar Therapeutics (NKTR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Nektar Therapeutics's latest dividend and current dividend yield?What guidance did Nektar Therapeutics's management provide for the next earnings period?What does Nektar Therapeutics do and what are its main business segments?What is the revenue and EPS growth rate for Nektar Therapeutics year over year?What is Nektar Therapeutics's gross profit margin?What were the key takeaways from Nektar Therapeutics's earnings call?What factors drove the changes in Nektar Therapeutics's revenue and profit?What is the market's earnings forecast for Nektar Therapeutics next quarter?
